Pesquisas alternativas:
safety alert » safety alerts (Expandir a Pesquisa), safety belt (Expandir a Pesquisa), safety audit (Expandir a Pesquisa)
armed phase » formed phase (Expandir a Pesquisa), aided phase (Expandir a Pesquisa), red phase (Expandir a Pesquisa)
phase 1 » phase _ (Expandir a Pesquisa), phase 2 (Expandir a Pesquisa)
safety alert » safety alerts (Expandir a Pesquisa), safety belt (Expandir a Pesquisa), safety audit (Expandir a Pesquisa)
armed phase » formed phase (Expandir a Pesquisa), aided phase (Expandir a Pesquisa), red phase (Expandir a Pesquisa)
phase 1 » phase _ (Expandir a Pesquisa), phase 2 (Expandir a Pesquisa)
81
Por Diéras, Véronique, Rugo, Hope S, Schnell, Patrick, Gelmon, Karen, Cristofanilli, Massimo, Loi, Sherene, Colleoni, Marco, Lu, Dongrui R, Mori, Ave, Gauthier, Eric, Huang Bartlett, Cynthia, Slamon, Dennis J, Turner, Nicholas C, Finn, Richard S
Publicado no J Natl Cancer Inst (2018)
“...-term PALOMA safety data longitudinally. METHODS: Data were pooled from three randomized phase II...”Publicado no J Natl Cancer Inst (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
82
Por Takeuchi, Tsutomu, Yamanaka, Hisashi, Harigai, Masayoshi, Tamamura, Ryo, Kato, Yuichi, Ukyo, Yoshifumi, Nakano, Toshikazu, Hsu, Benjamin, Tanaka, Yoshiya
Publicado no Arthritis Res Ther (2018)
“... to interleukin-6, has demonstrated efficacy in the treatment of rheumatoid arthritis (RA) in global phase 1...”Publicado no Arthritis Res Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
83
Por Ailani, Jessica, Lipton, Richard B., Hutchinson, Susan, Knievel, Kerry, Lu, Kaifeng, Butler, Matthew, Yu, Sung Yun, Finnegan, Michelle, Severt, Lawrence, Trugman, Joel M.
Publicado no Headache (2020)
“... with migraine with or without aura entered the trial after completing one of 2 phase 3 lead‐in trials and were...”Publicado no Headache (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
84
Por Ordoñez-Boschetti, Laura, Rey, Roberto, Cruz, Ana, Sinha, Arijit, Reynolds, Tracy, Frider, Nadina, Alvarenga, Regina
Publicado no Adv Ther (2015)
“... in this 16-week, single treatment arm, open-label, multi-center study. Unlike the phase III pivotal studies...”Publicado no Adv Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
85
Por Rahman, Ridwanur, Goyal, Vishal, Haque, Rashidul, Jamil, Kazi, Faiz, Abul, Samad, Rasheda, Ellis, Sally, Balasegaram, Manica, den Boer, Margriet, Rijal, Suman, Strub-Wourgaft, Nathalie, Alves, Fabiana, Alvar, Jorge, Sharma, Bhawna
Publicado no PLoS Negl Trop Dis (2017)
“... given in 5 mg/kg doses on days 1, 3 and 5. This was a phase III open label, individually randomized...”Publicado no PLoS Negl Trop Dis (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
86
Por Chang, Sung Hae, Song, Yun-Kyung, Nah, Seong-Su
Publicado no Evid Based Complement Alternat Med (2018)
“... ± 1.5 (p = 0.84). After 6 weeks, the pain VAS was 43.0 ± 2.5, resp. 61.6 ± 2.5 (p < 0.01) and the total...”Publicado no Evid Based Complement Alternat Med (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
87
“... ± 1.5 (p = 0.84). After 6 weeks, the pain VAS was 43.0 ± 2.5, resp. 61.6 ± 2.5 (p < 0.01) and the total...”
Obter o texto integral
Obter o texto integral
Artigo
88
Por Belkouz, Ali, de Vos-Geelen, Judith, Mathôt, Ron A. A., Eskens, Ferry A. L. M., van Gulik, Thomas M., van Oijen, Martijn G. H., Punt, Cornelis J. A., Wilmink, Johanna W., Klümpen, Heinz-Josef
Publicado no Br J Cancer (2020)
“... patients were enrolled at a starting dose as defined in stage one, provided that in stage ≥1 objective...”Publicado no Br J Cancer (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
89
Por Creech, C Buddy, Dekker, Cornelia L, Ho, Dora, Phillips, Shanda, Mackey, Sally, Murray-Krezan, Cristina, Grazia Pau, Maria, Hendriks, Jenny, Brown, Valerie, Dally, Leonard G, Versteege, Isabella, Edwards, Kathryn M
Publicado em 2013
“... vaccines can provide protection against infection. A Phase 1, randomized, placebo-controlled, dose...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
90
Por Marty, Francisco M., Man, Choy Y., van der Horst, Charles, Francois, Bruno, Garot, Denis, Máňez, Rafael, Thamlikitkul, Visanu, Lorente, José A., Álvarez-Lerma, Francisco, Brealey, David, Zhao, Henry H., Weller, Steve, Yates, Phillip J., Peppercorn, Amanda F.
Publicado em 2014
“... in viral load of 1.42 log(10) copies/mL after 2 days of treatment. Conclusions. Safety, pharmacokinetic...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
91
Por Nieschlag, Eberhard, Bouloux, Pierre-Marc G., Stegmann, Barbara J., Shankar, R. Ravi, Guan, Yanfen, Tzontcheva, Anjela, McCrary Sisk, Christine, Behre, Hermann M.
Publicado no Reprod Biol Endocrinol (2017)
“... of this study was to investigate the efficacy and safety of corifollitropin alfa combined with hCG to increase...”Publicado no Reprod Biol Endocrinol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
92
Por Islam, Badrul, Islam, Zhahirul, Rahman, Shafiqur, Endtz, Hubert P, Vos, Margreet C, van der Jagt, Mathieu, van Doorn, Peter A, Jacobs, Bart C, Mohammad, Quazi Deen
Publicado no BMJ Open (2018)
“...OBJECTIVE: To assess the safety and feasibility of small volume plasma exchange (SVPE) for patients...”Publicado no BMJ Open (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
93
Por Withers, Mark R, McKinney, Denise, Ogutu, Bernhards R, Waitumbi, John N, Milman, Jessica B, Apollo, Odika J, Allen, Otieno G, Tucker, Kathryn, Soisson, Lorraine A, Diggs, Carter, Leach, Amanda, Wittes, Janet, Dubovsky, Filip, Stewart, V. Ann, Remich, Shon A, Cohen, Joe, Ballou, W. Ripley, Holland, Carolyn A, Lyon, Jeffrey A, Angov, Evelina, Stoute, José A, Martin, Samuel K, Heppner, D. Gray
Publicado em 2006
“... stable and similar across arms. Baseline geometric mean titers were comparable in all groups. Anti-FMP1...”Publicado em 2006
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
94
Por Piratvisuth, Teerha, Komolmit, Piyawat, Tanwandee, Tawesak, Sukeepaisarnjaroen, Wattana, Chan, Henry L. Y., Pessôa, Mário G., Fassio, Eduardo, Ono, Suzane K., Bessone, Fernando, Daruich, Jorge, Zeuzem, Stefan, Cheinquer, Hugo, Pathan, Rashidkhan, Dong, Yuhong, Trylesinski, Aldo
Publicado em 2013
“... for the intensification of nucleoside analogue monotherapy based on early virologic response. The efficacy and safety...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
95
Por Wilder, Julius M., Jeffers, Lennox J., Ravendhran, Natarajan, Shiffman, Mitchell L., Poulos, John, Sulkowski, Mark S., Gitlin, Norman, Workowski, Kimberly, Zhu, Yanni, Yang, Jenny C., Pang, Phillip S., McHutchison, John G., Muir, Andrew J., Howell, Charles, Kowdley, Kris, Afdhal, Nezam, Reddy, K. Rajender
Publicado no Hepatology (2015)
“...Black patients chronically infected with genotype 1 hepatitis C virus (HCV) have historically had...”Publicado no Hepatology (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
96
Por Grossman, R, Bokstein, F, Ben Harosh, C, Blumenthal, D, Limon, D, Ram, Z
Publicado no Neuro Oncol (2018)
“... treatment comprising low intensity alternating electric fields. In the phase 3 EF14 study in newly diagnosed...”Publicado no Neuro Oncol (2018)
Obter o texto integral
Obter o texto integral
Artigo
97
Por Brandes, Alba, Gil, Miquel Gil, Saran, Frank, Carpentier, Antoine F, Nowak, Anna, Mason, Warren, Dubois, Francois, Finocchiaro, Gaetano, Fountzilas, George, Zagonel, Vittorina, Cernea, Dana M, Chinot, Olivier, Makrutzki, Martina, Mpofu, Chiedzo, Urban, Hans-Joerg, Pichler, Josef
Publicado no Neuro Oncol (2017)
“...). After PD1, patients were randomized to receive lomustine (CCNU) plus BEV or CCNU + placebo (P) until PD2...”Publicado no Neuro Oncol (2017)
Obter o texto integral
Obter o texto integral
Artigo
98
Por Spitzer, Andrew I., Richmond, John C., Kraus, Virginia B., Gomoll, Andreas, Jones, Deryk G., Huffman, Kim M., Peterfy, Charles, Cinar, Amy, Lufkin, Joelle, Kelley, Scott D.
Publicado no Rheumatol Ther (2019)
“...), including those with advanced radiographic severity. METHODS: In this phase 3b, single-arm, open-label study...”Publicado no Rheumatol Ther (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
99
Por Margolis, David, Sutton, Kenneth, De Vente, Jerome, LeBlanc, Roger, DeJesus, Edwin, Smith, Graham, Mills, Anthony, Baril, Jean-Guy, St. Clair, Marty, Stancil, Britt, Williams, Peter, Spreen, William
Publicado no Open Forum Infect Dis (2019)
“... to the EFV arm. After W96, at the start of the open-label (OL) phase, all patients randomized to CAB were...”Publicado no Open Forum Infect Dis (2019)
Obter o texto integral
Obter o texto integral
Artigo
100
Por Greten, Tim F, Forner, Alejandro, Korangy, Firouzeh, N'Kontchou, Gisele, Barget, Nathalie, Ayuso, Carmen, Ormandy, Lars A, Manns, Michael P, Beaugrand, Michel, Bruix, Jordi
Publicado em 2010
“... major investigation. In this open label, single arm clinical trial, we analyzed the effect of a low dose...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo